Jérémie Calais, MD, MSc, University of California, Los Angeles, and Christopher Wallis, MD, PhD, University of Toronto, discuss a post-hoc analysis assessing the outcomes of 176 patients treated with PSMA PET guided salvage RT, which demonstrated it to be an effective method for treating both pelvic and extrapelvic recurrent prostate cancer.